Archive

Adding obesity experts to primary care clinics improves patients’ weight loss outcomes

Written by | 24 May 2024

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to […]

Few newly diagnosed type 2 diabetics succeed in losing weight – weight gain linked to much higher risk of complications

Written by | 11 Apr 2024

A register-based study from Finland identified three distinct BMI trajectory groups among patients with newly diagnosed type 2 diabetes. In a four-year follow-up, most patients followed a stable […]

Very low calorie diets are safe and acceptable for teenagers with moderate to severe obesity when used short-term and supported by a dietitian, Australian study finds

Written by | 22 Mar 2024

Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at […]

New weight loss medication may help lower blood pressure in adults with obesity

Written by | 5 Feb 2024

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took […]

Almost 1:10 adolescents non-prescription weight loss products globally

Written by | 15 Jan 2024

One in ten adolescents globally have used ineffective and potentially harmful non prescribed weight loss products in their lifetime, with 2% using them in the previous week. A […]

Science’s 2023 Breakthrough of the Year: GLP-1 agonists show promise for obesity-associated health problems

Written by | 21 Dec 2023

Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The […]

Alarm over lax oversight of weight loss drug ads that could harm patients

Written by | 19 Dec 2023

UK organisations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms of weight loss drugs by not enforcing the law, […]

Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain

Written by | 15 Dec 2023

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine […]

EU drug watchdog warns of fake Ozempic pens

Written by | 22 Oct 2023

The European Medicines Agency (EMA) is warning patients and healthcare professionals to beware of pre-filled pens falsely labelled as Ozempic, a diabetes medicine linked to weight loss. National […]

Semaglutide (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss

Written by | 5 Oct 2023

Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up […]

NHS England moves to restrict use of GLP-1 agonists

Written by | 10 Jul 2023

On 27th June 2023 NHS England issued a Medicine Supply Notification (MSN/2023/061) concerning GLP-1 receptor agonists (GLP-1 RAs) used for management of type 2 diabetes. This action has […]

Behavior patterns of people who achieve clinically significant weight loss

Written by | 9 May 2023

A new study analyzing data on over 20,000 U.S. adults links a healthier diet and increased exercise to weight loss that reduces heart disease risk – while associating […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.